[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (459)

Search Parameters:
Keywords = propylene glycol

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
27 pages, 3818 KiB  
Article
In Situ Gelling Dexamethasone Oromucosal Formulation: Physical Characteristics Influencing Drug Delivery
by Daniel Krchňák, Ľudmila Balážová, Michal Hanko, Dominika Žigrayová and Miroslava Špaglová
Gels 2025, 11(1), 26; https://doi.org/10.3390/gels11010026 - 2 Jan 2025
Viewed by 382
Abstract
The study focuses on the development of an in situ gelling dexamethasone (DEX) oromucosal formulation designed for the treatment of aphthous stomatitis. Three series of formulations were prepared; a first series containing DEX suspended, a second series containing DEX and, in addition, mint [...] Read more.
The study focuses on the development of an in situ gelling dexamethasone (DEX) oromucosal formulation designed for the treatment of aphthous stomatitis. Three series of formulations were prepared; a first series containing DEX suspended, a second series containing DEX and, in addition, mint essential oil (EO), and a third series containing EO and DEX solubilized in propylene glycol (PG). In the composition, polymers in the role of mucoadhesive agent were interchanged (hydroxypropyl methylcellulose (HPMC), hydroxypropyl cellulose (HPC), hydroxyethyl cellulose (HEC), methyl cellulose (MC), carboxymethyl cellulose (CMC), and sodium carboxymethyl cellulose (NaCMC). Specifically, DEX was incorporated at a concentration of 0.1% (w/w) in each formulation. The influence of mint EO and DEX solubilization on the physical properties (pH measurements, rheological analysis, swelling ability, and texture analysis) and in vitro drug release was studied. Key findings revealed that HPMC-based formulation containing mint EO and PG exhibited best swelling properties (700 ± 46% after 5 h), adequate adhesiveness and in vitro drug release (34.7 ± 5.9%). Furthermore, the irritation potential assessed via the hen’s egg test on the chorioallantoic membrane (HET-CAM) demonstrated low irritancy risk. Finally, Fourier-transform infrared spectroscopy (FT-IR) showed no incompatibility between DEX and excipients. Overall, the research highlights the potential of mucoadhesive systems in improving the therapeutic efficacy of oromucosal drug delivery for managing painful oral lesions. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>The comparison of the swelling ability of the formulations without essential oil (EO) (first series) and with EO and DEX solubilized in propylene glycol (PG) (third series). The difference in swelling ability of all formulations is statistically significant (*) compared to the reference samples A1 or A3 with HPMC.</p>
Full article ">Figure 2
<p>Macroscopic observation of changes in the sample formulations after 5 h of swelling in the artificial saliva.</p>
Full article ">Figure 3
<p>FT-IR spectra of DEX (red), formulation A3 with DEX (green), zoomed spectra of formulation A3 with DEX (blue), and formulation A3 without DEX (black).</p>
Full article ">Figure 4
<p>In vitro release profiles of DEX from the formulations without essential oil (EO), with essential oil (EO), and with essential oil (EO) and DEX solubilized in propylene glycol (PG). A1, A2 and A3 were used as the reference samples in the series of formulations being compared. NS indicates a non-significant difference, two asterisks (**) a significant difference at a high level with <span class="html-italic">p</span> ≤ 0.01, and three asterisks (***) a significant difference at a very high level with <span class="html-italic">p</span> ≤ 0.001.</p>
Full article ">Figure 5
<p>The amount of DEX (%) released after 4 h during in vitro release study from the formulations. The asterisk (*) indicates a significant difference with respect to the corresponding reference sample from series one, without EO and PG. The formulations without EO (blue), with EO (green), with EO and PG (yellow).</p>
Full article ">Figure 6
<p>The microscopic observation of the chorioallantoic membrane after application of the examined formulations (green circles—hemorrhage, yellow circles—vasodilatation).</p>
Full article ">
14 pages, 3619 KiB  
Article
Bioadhesive Chitosan Films Loading Curcumin for Safe and Effective Skin Cancer Topical Treatment
by Seila Tolentino, Mylene M. Monteiro, Felipe Saldanha-Araújo, Marcilio Cunha-Filho, Tais Gratieri, Eliete N. Silva Guerra and Guilherme M. Gelfuso
Pharmaceutics 2025, 17(1), 18; https://doi.org/10.3390/pharmaceutics17010018 - 26 Dec 2024
Viewed by 440
Abstract
Background/Objectives: This study aimed to evaluate the safety and efficacy of chitosan-based bioadhesive films for facilitating the topical delivery of curcumin in skin cancer treatment, addressing the pharmacokinetic limitations associated with oral administration. Methods: The films, which incorporated curcumin, were formulated [...] Read more.
Background/Objectives: This study aimed to evaluate the safety and efficacy of chitosan-based bioadhesive films for facilitating the topical delivery of curcumin in skin cancer treatment, addressing the pharmacokinetic limitations associated with oral administration. Methods: The films, which incorporated curcumin, were formulated using varying proportions of chitosan, polyvinyl alcohol, Poloxamer® 407, and propylene glycol. These films were assessed for stability, drug release, in vitro skin permeation, cell viability (with and without radiotherapy), and skin irritation. Results: The films demonstrated physical stability and preserved curcumin content at room temperature for 90 days. Drug release was effectively controlled during the first 8 h, with release rates ranging from 51.6 ± 4.8% to 65.6 ± 13.0%. The films also enhanced drug penetration into the skin compared to a curcumin solution used as a control (stratum corneum: 1.3 ± 0.1 to 1.9 ± 0.8 µg/cm²; deeper skin layers: 1.7 ± 0.1 to 2.7 ± 0.2 µg/cm²). A cytotoxicity test on metastatic melanoma cells showed that curcumin at topical doses exerted activity similar to that delivered via the skin. Furthermore, curcumin alone was more effective in inhibiting tumor cells than radiotherapy alone (p < 0.01), with no additional benefit observed when curcumin was combined with radiotherapy. Finally, irritation tests confirmed that the films were safe for topical application. Conclusion: The developed chitosan-based bioadhesive films represent a promising alternative for the topical treatment of skin tumors using curcumin. Full article
Show Figures

Figure 1

Figure 1
<p>Images captured from the F1, F2, and F3 films at the predefined times for the stability study (0, 7, 30, 60, and 90 days) and variation in curcumin content over time. The storage conditions were room temperature (RT) and 40 °C.</p>
Full article ">Figure 2
<p>Curcumin release profiles from films (F1, F2, and F3) over 24 h, with collections at 1, 2, 4, 6, 8, 18, 20, 22, and 24 h and recording photographs of the films at the end of the study.</p>
Full article ">Figure 3
<p>Curcumin recovered from the skin layers (µg/cm<sup>2</sup>) after a 24 h treatment with the films compared to the control. (<b>a</b>) Stratum corneum, (<b>b</b>) remaining skin. The data represent the mean of 5 determinations ± standard deviation. #, values below the limit of quantification; (*), <span class="html-italic">p</span> ≤ 0.05; and (****), <span class="html-italic">p</span> ≤ 0.0001.</p>
Full article ">Figure 4
<p>Effect of curcumin on the viability of MeWo cell line. The Kruskal–Wallis test was employed for cell viability data, and IC<sub>50</sub> values were calculated following nonlinear regression on dose–response curves. The data are presented as the mean ± standard deviation (<span class="html-italic">n</span> = 9). (**), <span class="html-italic">p</span> ≤ 0.01; and (****), <span class="html-italic">p</span> ≤ 0.0001.</p>
Full article ">Figure 5
<p>Effect of curcumin on the viability of MeWo cell line, with or without three different doses of radiotherapy. The data are presented as the mean ± standard deviation (<span class="html-italic">n</span> = 9). Statistical analysis was performed using ANOVA. (*), <span class="html-italic">p</span> ≤ 0.05; (**), <span class="html-italic">p</span> ≤ 0.01; and (***); <span class="html-italic">p</span> ≤ 0.001.</p>
Full article ">Figure 6
<p>Illustrative sequence of photographic records taken during the HET-CAM assay demonstrating the effects with positive control (1.0 mol/L NaOH), negative control (PBS), and solutions containing each of the films (F1, F2, and F3) solubilized in water on the chorioallantoic membrane after 30 s, 2 min, and 5 min of application.</p>
Full article ">Figure 7
<p>Effect of chitosan on the viability of the human keratinocytes (HaCaT cell line). The Kruskal–Wallis test was employed for cell viability data. Due to the sustained cell viability, it was not possible to calculate the IC<sub>50</sub> from the obtained dose–response curve. The data are presented as the mean ± standard deviation (<span class="html-italic">n</span> = 9).</p>
Full article ">
9 pages, 1320 KiB  
Article
Effects of E-Cigarette (e-cig) Aerosols on Mutagenesis in Selected Organs in a C57 lacI (BigBlueTM) Mouse Model
by Dweet Chhaya, Merna Gress, Amna Raja, Wieslawa Kosinska, Terry Gordon, Judith Zelikoff and Joseph B. Guttenplan
Int. J. Environ. Res. Public Health 2024, 21(12), 1693; https://doi.org/10.3390/ijerph21121693 - 19 Dec 2024
Viewed by 624
Abstract
The objective of this study is to investigate the potential mutagenic effects of the exposure of mice to aerosols produced from the component liquids of an electronic nicotine delivery system (ENDS). The use of electronic cigarettes (e-cigs) and ENDSs has increased tremendously over [...] Read more.
The objective of this study is to investigate the potential mutagenic effects of the exposure of mice to aerosols produced from the component liquids of an electronic nicotine delivery system (ENDS). The use of electronic cigarettes (e-cigs) and ENDSs has increased tremendously over the past two decades. From what we know to date, ENDSs contain much lower levels of known carcinogens than tobacco smoke. While conventional tobacco smoke is a well-established mutagen, little is known about the mutagenicity of ENDS aerosols. Here, we report the mutagenic effects of a 3-month whole body exposure of C57 lacI mice (BigBlueTM) to filtered air (AIR) or ENDS aerosols in several tissues. Aerosols were generated from a 50/50 vegetable glycerin (VG)/propylene glycol (PG) mixture with and without nicotine. The results revealed that in the lung, bladder urothelial tissue, and tongue, mutagenesis was significantly greater in the VG/PG/nicotine group than in the AIR group. In all organs except the bladder, mutagenesis in the VG/PG only group was similar to those exposed to AIR. In the bladder, mutagenesis in the VG/PG group was elevated compared to that in the AIR group. In the liver, mutagenesis was modestly elevated in the VG/PG/nicotine group, but the elevation failed to reach statistical significance. Overall, there were no consistent differences in mutagenesis between the sexes. The results of this study suggest that exposure to e-cig aerosols containing nicotine represents a risk factor for carcinogenesis in several organ systems, and exposure to VG/PG alone may be a risk factor for bladder cancer. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Effect of 3-month whole-body exposure of C57 <span class="html-italic">lacI</span> mice (Big Blue) to e-cig aerosols or filtered air on mutagenesis in lung. E-cig aerosol without nicotine (VG/PG); E-cig aerosol with nicotine, (VG/PG/nic), pfu (plaque-forming units). All groups consist of females + males. n = 13 for air, 10 for VG/PG, and 12 for VG/PG/nic groups. *, <span class="html-italic">p</span> ≤ 0.01 vs. filtered air in one-tailed <span class="html-italic">t</span>-test; error bars, mean ± SEM. MF, mutant fraction.</p>
Full article ">Figure 2
<p>Effect of 3-month whole-body exposure of C57 <span class="html-italic">lacI</span> mice (Big Blue) to e-cig aerosols or filtered air on mutagenesis in tongue. E-cig aerosol without nicotine (VG/PG); E-cig aerosol with nicotine, (VG/PG/nic), pfu (plaque-forming units). All groups consist of females + males. n = 13 for air, 10 for VG/PG, and 12 for VG/PG/nic groups. *, <span class="html-italic">p</span> ≤ 0.05 vs. filtered air group in one-tailed <span class="html-italic">t</span>-test; error bars, mean ± SEM.</p>
Full article ">Figure 3
<p>Effect of 3-month whole-body exposure of C57 <span class="html-italic">lacI</span> mice (Big Blue) to e-cig aerosols or filtered air on mutagenesis in bladder urothelial tissue. E-cig aerosol without nicotine (VG/PG); E-cig aerosol with nicotine, (VG/PG/nic), pfu (plaque-forming units). All groups consist of females + males. n = 13 for air, 10 for VG/PG, and 9 for VG/PG/nic groups. *, <span class="html-italic">p</span> &lt; 0.02 vs. filtered air group in one-tailed <span class="html-italic">t</span>-test; error bars, mean ± SEM.</p>
Full article ">Figure 4
<p>Effect of 3-month whole-body exposure of C57 <span class="html-italic">lacI</span> mice (Big Blue) to e-cig aerosols or filtered air on mutagenesis in liver. E-cig aerosol without nicotine (VG/PG); E-cig aerosol with nicotine, (VG/PG/nic), pfu (plaque-forming units). All groups consist of females + males. n = 13 for air, 10 for VG/PG, and 12 for VG/PG/nic groups. Error bars, mean ± SEM.</p>
Full article ">
23 pages, 2054 KiB  
Article
Characterization and Safety Assessment of a Novel Antioxidant Excipient from Sustainable Recovery of Grape Processing Waste Bentonite Designed to Develop a Thermosensitive Buccal Spray for Oral Cavity Wellness
by Giulia Di Prima, Elena Belfiore, Cecilia La Mantia, Serena Indelicato, Giuseppe Avellone and Viviana De Caro
Pharmaceutics 2024, 16(12), 1612; https://doi.org/10.3390/pharmaceutics16121612 - 19 Dec 2024
Viewed by 483
Abstract
Background/Objectives: Nowadays, sustainability efforts focus on extracting natural cosmeceutical ingredients, such as polyphenols, from agri-food waste, for example, black bentonite (BB). The aims of this work were to validate an antioxidant cosmetic ingredient obtained from the waste BB and embed it into an [...] Read more.
Background/Objectives: Nowadays, sustainability efforts focus on extracting natural cosmeceutical ingredients, such as polyphenols, from agri-food waste, for example, black bentonite (BB). The aims of this work were to validate an antioxidant cosmetic ingredient obtained from the waste BB and embed it into an ad hoc designed oromucosal spray intended for oral cavity wellness. Methods: Focusing on sustainability, the study tested PEG200, propylene glycol, and their mixtures as unconventional and green extraction solvents, aligned with a waste-to-market approach. The extracts obtained by maceration were characterized through HPLC-DAD and HPLC-MS analyses, DPPH, Bradford, and Folin–Ciocalteu assays. The best P extract was further subjected to OECD-compliant in vitro validation as novel cosmetic raw material and used to prepare a thermosensitive buccal spray for oral daily care. Results: PEG200 enabled the obtainment of a cost-effective polyphenol-rich extract, which was validated as a safe, high value-added cosmetic secondary raw material. The extract was incorporated into a liquid thermosensitive buccal formulation, able to gel once at body temperature and enhance polyphenol accumulation into the oral mucosae even with short contact times. Conclusions: BB is confirmed as a valuable source of polyphenols, and PEG200 represents an effective extraction solvent leading to a novel functional liquid excipient characterized by an OECD-compliant variegate pool of phenols. The buccal spray then proposed represents a valuable, friendly solution for daily oral care, as it is simple to use, as well as the in vitro and ex vivo tests carried out suggested its effectiveness. Full article
(This article belongs to the Special Issue Pharmaceuticals Based on or Loaded with Natural Products)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Antioxidant power of the green extracts reported as residual DPPH % over time until 1 h. Means (n = 18) ± SE (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 2
<p>In vitro (<b>A</b>) skin and (<b>B</b>) eye irritation assays: cell viability % referred to control cells (treated with PBS or sterile water) after treatment with the positive control (SLS or MA) and the P extract (10% <span class="html-italic">w</span>/<span class="html-italic">v</span> solution in sterile water). The experiments were conducted in accordance with the OECD 439 and 492 guidelines by using a 3D human artificial skin model (EpiDerm<sup>TM</sup>) or a 3D human corneal epithelium model (EpiOcular<sup>TM</sup>), respectively. Means (n = 3) ± SD (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 3
<p>In vitro skin sensitizing power against the THP-1 cell line (ATCC TIB-202): (<b>A</b>), preliminary studies of cell viability % referred to control cells to evaluate the maximum P extract dose useful to evaluate the (<b>B</b>) CD54 and (<b>C</b>) CD86 expression by fluorescence. Data are compared to a negative control treated with cell culture medium and to a positive control treated with DNCB. The skin sensitizing threshold according to the OECD 442E is highlighted. Means (n = 9) ± SD (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 4
<p>In vitro qualitative assay to verify the temperature-dependent gelation behavior of the buccal formulation when sprayed on a watch glass at (<b>A</b>) room temperature and (<b>B</b>) 37 ± 1 °C.</p>
Full article ">Figure 5
<p>Extensibility profile measured by increasing applied weights of the thermosensitive formulation kept at (<b>A</b>) 25 ± 1 °C (green rhombus) and (<b>B</b>) 37 ± 1 °C (purple rhombus) (<span class="html-italic">p</span> &lt; 0.01).</p>
Full article ">Figure 6
<p>Percentage amount of GA, RSV, and QRC entrapped into the (<b>A</b>) buccal and (<b>B</b>) sublingual mucosae after different incubation times with the buccal in situ gelling formulation. Means (n = 6) ± SE (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">
14 pages, 13934 KiB  
Article
Effects of Different Plasticizers on the Structure, Physical Properties and Film Forming Performance of Curdlan Edible Films
by Ying Chen, Jing Wang, Liang Xu, Yuping Nie, Yunyue Ye, Jianya Qian, Fengsong Liu and Liang Zhang
Foods 2024, 13(23), 3930; https://doi.org/10.3390/foods13233930 - 5 Dec 2024
Viewed by 987
Abstract
This study successfully developed edible films with excellent mechanical strength and notable water resistance, utilizing curdlan (CL) as the primary matrix and incorporating various plasticizers, including glycerol (GLY), ethylene glycol (EG), propylene glycol (PRO), xylitol (XY), sorbitol (SOR), and polyethylene glycol (PEG). A [...] Read more.
This study successfully developed edible films with excellent mechanical strength and notable water resistance, utilizing curdlan (CL) as the primary matrix and incorporating various plasticizers, including glycerol (GLY), ethylene glycol (EG), propylene glycol (PRO), xylitol (XY), sorbitol (SOR), and polyethylene glycol (PEG). A comprehensive suite of analytical techniques, including Fourier transform infrared spectroscopy (FTIR), wide-angle X-ray diffraction (XRD), scanning electron microscopy (SEM), dynamic mechanical analysis (DMA), and tensile testing, were employed to evaluate the films’ structural and mechanical properties. After incorporating PEG, the water sensitivity increased slightly, with a contact angle (CA) of 97.6°, and a water solubility (WS) of 18.75%. The inclusion of plasticizers altered the crystalline structure of the CL matrix, smoothing and flattening the film surface while reducing hydrogen-bonding interactions. These structural changes led to a more uniform distribution of amorphous chain segments and a decrease in glass transition temperatures. Among the tested plasticizers, GLY exhibited the highest compatibility with CL, resulting in the smoothest surface morphology and delivering the most effective plasticizing effect. The CL-GLY film showed a dramatic improvement in flexibility, with an elongation at break that was 5.2 times higher than that of the unplasticized film (increasing from 5.39% to 33.14%), indicating significant enhancement in extensibility. Overall, these findings highlight the potential of CL-GLY films as sustainable and effective materials for food packaging applications. Full article
(This article belongs to the Special Issue Natural Polymer-Based Films and Coatings for Food Packaging)
Show Figures

Figure 1

Figure 1
<p>Wide-angle XRD pattern of CL edible film with different plasticizers.</p>
Full article ">Figure 2
<p>Surface and cross-sectional of CL edible film with different plasticizers. CL (<b>A</b>,<b>a</b>); CL-GLY (<b>B</b>,<b>b</b>); CL-EG (<b>C</b>,<b>c</b>); CL-PRO (<b>D</b>,<b>d</b>); CL-XY (<b>E</b>,<b>e</b>); CL-SOR (<b>F</b>,<b>f</b>); CL-PEG (<b>G</b>,<b>g</b>).</p>
Full article ">Figure 3
<p>Fourier transform infrared spectrogram of CL edible film with different plasticizers.</p>
Full article ">Figure 4
<p>Dynamic thermomechanical properties of CL edible films with different plasticizers.</p>
Full article ">Figure 5
<p>Light transmittance diagram of CL edible films with different plasticizers.</p>
Full article ">Figure 6
<p>Hydrophobicity of the CL films. (<b>a</b>) CA; (<b>b</b>) WS; (<b>c</b>) swelling ratio; (<b>d</b>) WVP. The values were reported as Mean ± SD and statiscal significance is denoted by different letters (<span class="html-italic">p</span> &lt; 0.05, Tukey’s test in one-way ANOVA).</p>
Full article ">Figure 7
<p>Mechanical properties of CL edible film with different plasticizers. The values were reported as Mean ± SD and statiscal significance is denoted by different letters (<span class="html-italic">p</span> &lt; 0.05, Tukey’s test in one-way ANOVA).</p>
Full article ">Scheme 1
<p>Diagram of the fabrication of CL films.</p>
Full article ">
20 pages, 7172 KiB  
Article
Eutectogel-Based Drug Delivery: An Innovative Approach for Atenolol Administration
by Roberta Cassano, Roberta Sole, Carlo Siciliano, Noemi Baldino, Olga Mileti, Debora Procopio, Federica Curcio, Gabriella Calviello, Simona Serini, Sonia Trombino and Maria Luisa Di Gioia
Pharmaceutics 2024, 16(12), 1552; https://doi.org/10.3390/pharmaceutics16121552 - 4 Dec 2024
Viewed by 673
Abstract
Background: Hypertension affects 32% of adults worldwide, leading to a significant global consumption of cardiovascular medications. Atenolol, a β-adrenergic receptor blocker, is widely prescribed for cardiovascular diseases such as hypertension, angina pectoris, and myocardial infarction. According to the Biopharmaceutics Classification System (BCS), atenolol [...] Read more.
Background: Hypertension affects 32% of adults worldwide, leading to a significant global consumption of cardiovascular medications. Atenolol, a β-adrenergic receptor blocker, is widely prescribed for cardiovascular diseases such as hypertension, angina pectoris, and myocardial infarction. According to the Biopharmaceutics Classification System (BCS), atenolol belongs to Class III, characterized by high solubility but low permeability. Currently, atenolol is commercially available in oral formulations. Increasing attention is being directed towards developing cost-effective transdermal delivery systems, due to their ease of use and better patient compliance. Eutectogels represent next-generation systems that are attracting great interest in the scientific community. Typically obtained from deep eutectic solvents (DESs) combined with gelling agents, these systems exhibit unique properties due to the intrinsic characteristics of DESs. Methods: In this study, a DES based on choline chloride as a hydrogen bond acceptor (HBA) and propylene glycol as a hydrogen bond donor (HBD) was explored to enhance the topical delivery of atenolol. The solubility of atenolol in the DES was evaluated using spectroscopic and thermodynamic measurements which confirmed the formation of hydrogen bonds between the drug and DES components. Additionally, the safety of the DES was assessed in a cell viability assay. Subsequently, we formulated eutectogels with different concentrations using animal gelatin and Tego Carbomer 140, and characterized these formulations through rheological measurements, swelling percentage, and permeation studies with Franz cells. Results: These novel eutectogels exhibit superior performance over conventional hydrogels, with a release rate of approximately 86% and 51% for Carbomer- and gelatin-based eutectogels, respectively. In contrast, comparable hydrogels released only about 27% and 35%. Conclusions: These findings underscore the promising potential of eutectogels for the transdermal delivery of atenolol. Full article
(This article belongs to the Topic Challenges and Opportunities in Drug Delivery Research)
Show Figures

Figure 1

Figure 1
<p>Eutectogels prepared in this study.</p>
Full article ">Figure 2
<p>DSC thermograms of atenolol (ATL), ChCl:PG DES, and drug–DES mixture.</p>
Full article ">Figure 3
<p>FT-IR analysis of (ChCl:PG) DES, atenolol (ATL), and (ChCl:PG) DES with atenolol.</p>
Full article ">Figure 4
<p><sup>1</sup>H NMR spectra of atenolol (<b>A</b>) and DES (<b>B</b>).</p>
Full article ">Figure 4 Cont.
<p><sup>1</sup>H NMR spectra of atenolol (<b>A</b>) and DES (<b>B</b>).</p>
Full article ">Figure 5
<p>Homonuclear two-dimensional spectrum of the ChCl:PG DES.</p>
Full article ">Figure 6
<p><sup>1</sup>H NMR spectra of (ClCh:PG)DES-ATL (<b>A</b>) and <sup>13</sup>C NMR spectra of (ClCh:PG)DES-ATL (<b>B</b>).</p>
Full article ">Figure 6 Cont.
<p><sup>1</sup>H NMR spectra of (ClCh:PG)DES-ATL (<b>A</b>) and <sup>13</sup>C NMR spectra of (ClCh:PG)DES-ATL (<b>B</b>).</p>
Full article ">Figure 7
<p>The effect of increasing concentrations (0.5–5 µg/mL) of DES on the viability of human THP-1 monocytes and immortalized human NCTC 2544 keratinocytes treated for various periods (24–72 h). Values not sharing the same lowercase letter are significantly different (<span class="html-italic">p</span> &lt; 0.05, one-way ANOVA followed by Tukey’s test).</p>
Full article ">Figure 8
<p>The new eutectogels prepared: (<b>A</b>) gelatin-based eutectogel; (<b>B</b>) carbomer-based eutectogel.</p>
Full article ">Figure 9
<p>Time cure of gelatin–water-based gels (<b>a</b>,<b>c</b>) and gelatin–DES-based gels (<b>b</b>,<b>d</b>) in terms of complex modulus G* (<b>a</b>,<b>b</b>) and phase angle δ (<b>c</b>,<b>d</b>).</p>
Full article ">Figure 10
<p>Time cure of carbomer–water-based gels (<b>a</b>,<b>c</b>) and carbomer–DES-based gels (<b>b</b>,<b>d</b>) in terms of complex modulus G* (<b>a</b>,<b>b</b>) and phase angle (<b>c</b>,<b>d</b>).</p>
Full article ">Figure 11
<p>Comparison of A parameter for carbomer and gelatin in water and DES.</p>
Full article ">Figure 12
<p>Swelling of eutectogels and hydrogels with gelatin (<b>A</b>) and carbomer (<b>B</b>).</p>
Full article ">Figure 12 Cont.
<p>Swelling of eutectogels and hydrogels with gelatin (<b>A</b>) and carbomer (<b>B</b>).</p>
Full article ">Figure 13
<p>(<b>A</b>) Drug permeation by gels based on Carbomer 140–DES and Carbomer 140–water. (<b>B</b>) Drug release by gels based on gelatin–DES and gelatin–water.</p>
Full article ">Figure 13 Cont.
<p>(<b>A</b>) Drug permeation by gels based on Carbomer 140–DES and Carbomer 140–water. (<b>B</b>) Drug release by gels based on gelatin–DES and gelatin–water.</p>
Full article ">
13 pages, 1476 KiB  
Article
Investigating Strategies to Enhance the Aqueous Solubility of Ketamine HCl for Intranasal Delivery
by Sourour Idoudi, Alaaeldin Saleh, Mohammed Akkbik, Leena Amine, Khalid Alansari, Ousama Rachid and Alaaldin M. Alkilany
Pharmaceutics 2024, 16(12), 1502; https://doi.org/10.3390/pharmaceutics16121502 - 22 Nov 2024
Viewed by 730
Abstract
Background: Ketamine HCl, an FDA-approved therapeutic, is administered through various routes, including intranasal delivery. Administering an adequate therapeutic dose of intranasal ketamine HCl is challenging due to the limited volume that can be delivered intranasally given the current commercially available concentrations. Objectives: This [...] Read more.
Background: Ketamine HCl, an FDA-approved therapeutic, is administered through various routes, including intranasal delivery. Administering an adequate therapeutic dose of intranasal ketamine HCl is challenging due to the limited volume that can be delivered intranasally given the current commercially available concentrations. Objectives: This study investigates solubilizing strategies to enhance the aqueous solubility of ketamine HCl for intranasal administration. Methods: We assessed the solubility profile of ketamine HCl by evaluating factors such as pH, co-solvents, and surfactants. Additionally, we developed and validated a UV-Vis spectroscopy method for ketamine HCl analysis. Results: Our solubility screening in various organic co-solvents revealed the following order of effectiveness in enhancing solubility: methanol > water > propylene glycol > ethanol > dimethyl sulfoxide (DMSO) > N-methyl-2-pyrrolidone (NMP). Despite methanol’s superior solubility, its potential toxicity, coupled with the relatively lower effectiveness of other solvents compared to water, suggests that a co-solvency approach is not advantageous for ketamine HCl. We found that ketamine HCl solubility increased with medium acidity, with pH 3.5 being the optimal for further formulation studies. The impact of pharmaceutical surfactants on ketamine HCl solubility at an acidic pH was also evaluated. Surfactants tested included SDS, PEG 400, PVP, Tween 20, poloxamer 188, and lecithin. Notably, PEG 400 and PVP reduced solubility due to a salting-out effect, whereas Tween 80, lecithin, and poloxamer 188 slightly improved solubility through micelle formation. Among the surfactants tested, 1% SDS emerged as the most effective in enhancing ketamine HCl solubility. Conclusions: These outcomes highlight the potential of these solubilization strategies to address the solubility limitations of ketamine HCl, enabling the preparation of highly concentrated ketamine HCl formulations for intranasal delivery. Full article
(This article belongs to the Section Physical Pharmacy and Formulation)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Chemical structure of ketamine enantiomers. Both stereoisomers, (S)-ketamine and (R)-ketamine, are non-superimposable mirror images. Figure created in ChemDraw.</p>
Full article ">Figure 2
<p>(<b>A</b>) UV–Vis absorption spectrum of ketamine HCl (200 µg/mL) in 0.1 M CB, pH = 3.5 between 200 and 400 nm with λ<sub>max</sub> at 269 nm. (<b>B</b>) Calibration curve of ketamine HCl in 0.1 M CB, pH = 3.5 at 269 nm.</p>
Full article ">Figure 3
<p>UV–Vis absorption spectrum of ketamine HCl (200 µg/mL) in different solvents without (<b>A</b>) and with ketamine HCl (<b>B</b>), and in solutions of various surfactants without (<b>C</b>) and with ketamine HCl (<b>D</b>) in the range of 200–400 nm. Data are expressed as mean ± SD (<span class="html-italic">n</span> = 3).</p>
Full article ">Figure 4
<p>Solubility of ketamine HCl in different co-solvents. Data are expressed as mean ± SD (<span class="html-italic">n</span> = 3). Statistical significance was calculated using 1-way ANOVA and Dunnett’s test (**** <span class="html-italic">p</span> &lt; 0.0001 indicate statistical significance compared to water).</p>
Full article ">Figure 5
<p>Solubility of ketamine HCl as a function of pH in (<b>A</b>) 0.1 M CB and (<b>B</b>) 0.1 M PBS. Data are expressed as mean ± SD (<span class="html-italic">n</span> = 3). Statistical significance was calculated using 1-way ANOVA and Dunnett’s test (** <span class="html-italic">p</span> &lt; 0.01, and **** <span class="html-italic">p</span> &lt; 0.0001 indicate statistical significance compared to the pH 3.5 condition).</p>
Full article ">Figure 6
<p>Chemical structures of the used surfactants for ketamine HCl solubilization. Figure was created in ChemDraw.</p>
Full article ">Figure 7
<p>Solubility of ketamine HCl with different surfactants in CB with pH 3.5 (control) with different surfactants. Data are expressed as mean ± SD (<span class="html-italic">n</span> = 3). Statistical significance calculated using 1-way ANOVA and Dunnett’s test (ns = not significant, * <span class="html-italic">p</span> &lt; 0.05 indicate statistical significance compared to the control).</p>
Full article ">
15 pages, 3940 KiB  
Article
Supersaturated Liquid Formulation of Pazopanib Hydrochloride Loaded with Synergistic Precipitation Inhibitors
by Jin Woo Park, Sa-Won Lee, Jun Hak Lee, Jun-Pil Jee, Han-Joo Maeng, Dong-Jin Jang and Kwan Hyung Cho
Molecules 2024, 29(22), 5267; https://doi.org/10.3390/molecules29225267 - 7 Nov 2024
Cited by 1 | Viewed by 783
Abstract
This study aimed to develop a supersaturated liquid formulation (SSLF) to enhance the solubility and dissolution of pazopanib hydrochloride (PZH). SSLFs were prepared by a simple stirring method in a heated silicon oil bath (70 °C). PZH showed highly pH-dependent solubility (pH 1.2 [...] Read more.
This study aimed to develop a supersaturated liquid formulation (SSLF) to enhance the solubility and dissolution of pazopanib hydrochloride (PZH). SSLFs were prepared by a simple stirring method in a heated silicon oil bath (70 °C). PZH showed highly pH-dependent solubility (pH 1.2 > water >> pH 4.0 and pH 6.8) at 37 °C. The SSLF containing glycerol and polyvinylpyrrolidone K30 (PVP K30) increased PZH dispersion solubility (273.66 ± 48.91 μg/mL) at pH 6.8 by more than 50-fold compared with that of glycerol alone (<5 μg/mL), and the PZH precipitate particle size was considerably small (<100 nm). Moreover, the dispersion solubility of PZH from SSLF containing additional propylene glycol (PG) increased to 364.41 ± 2.47 μg/mL. The optimized SSLF10 (PZH/glycerol/PG/PVP K30 = 10/50/20/20, w/w) exhibited a high dissolution rate at pH 4.0 (>90%) and 6.8 (>55%) until 360 min, whereas PZH powder and PZH glycerol solution showed pH-dependent, low dissolution rates (<10%) under similar conditions. The supersaturation ratio of SSLF10 was very high at 29.88 and 18.36 at pH 6.8 and 4.0, respectively, indicating a stable PZH supersaturation solution. In the transmission electron microscopy analysis, PVP K30 and PG in SSLF10 synergistically suppressed PZH precipitation and recrystallization with small amorphous particles (<200 nm). Therefore, SSLF10 would be a promising formulation with enhanced solubility and dissolution rates regardless of medium pH. Full article
(This article belongs to the Special Issue Exclusive Feature Papers in Physical Chemistry, 2nd Edition)
Show Figures

Figure 1

Figure 1
<p>Chemical structure of PZH.</p>
Full article ">Figure 2
<p>PXRD patterns of raw PZH (a), residual PZH obtained from 1.2 buffer (b), pH 4.0 buffer (c), pH 6.8 buffer (d), and water (e).</p>
Full article ">Figure 3
<p>Solubility of PVPs in glycerol at room temperature and 70 °C.</p>
Full article ">Figure 4
<p>Solubility of PZH in vehicles at 70 °C.</p>
Full article ">Figure 5
<p>Dispersion solubility of PZH and particle size of PZH precipitates in SSLFs at pH 6.8.</p>
Full article ">Figure 6
<p>Dispersion solubility of PZH in SSLFs in pH 6.8 buffer solution at the initial time and 5 h. * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.005; N.S., no significant differences (<span class="html-italic">p</span> &gt; 0.05).</p>
Full article ">Figure 7
<p>Dissolution profiles of SSLF1, SSLF4, SSLF10, and PZH powder in pH 1.2 buffer (<b>a</b>), pH 4.0 buffer (<b>b</b>), pH 6.8 buffer (<b>c</b>), and water (<b>d</b>).</p>
Full article ">Figure 8
<p>Supersaturation ratio (S) of SSLF1, SSLF4, SSLF10, and PZH powder from the dissolution rate at 360 min in pH 6.8 buffer solution as in <a href="#molecules-29-05267-f007" class="html-fig">Figure 7</a>.</p>
Full article ">Figure 9
<p>Transmission electron microscopy (TEM) images of PZH powder (<b>a</b>) and PZH powder dispersed in water (<b>b</b>) and pH 6.8 buffer solution (<b>c</b>); precipitation particles from the dissolution test of SSLF1 (<b>d</b>), SSLF4 (<b>e</b>), and SSLF10 (<b>f</b>) at 2 h in pH 6.8 buffer solution.</p>
Full article ">
17 pages, 2926 KiB  
Article
Optimization of Glibenclamide Loaded Thermoresponsive SNEDDS Using Design of Experiment Approach: Paving the Way to Enhance Pharmaceutical Applicability
by Abdelrahman Y. Sherif, Ehab M. Elzayat and Mohammad A. Altamimi
Molecules 2024, 29(21), 5163; https://doi.org/10.3390/molecules29215163 - 31 Oct 2024
Viewed by 757
Abstract
Thermoresponsive self-nanoemulsifying drug delivery systems (T-SNEDDS) offer a promising solution to the limitations of conventional SNEDDS formulations. Liquid SNEDDS are expected to enhance drug solubility; however, they are susceptible to leakage during storage. Even though solid SNEDDS offers a solution to this storage [...] Read more.
Thermoresponsive self-nanoemulsifying drug delivery systems (T-SNEDDS) offer a promising solution to the limitations of conventional SNEDDS formulations. Liquid SNEDDS are expected to enhance drug solubility; however, they are susceptible to leakage during storage. Even though solid SNEDDS offers a solution to this storage instability, they introduce new challenges, namely increased total dosage and potential for drug trapping within the formulation. The invented T-SNEDDS was used to overcome these limitations and improve the dissolution of glibenclamide (GBC). Solubility and transmittance studies were performed to select a suitable oil and surfactant. Design of Experiments (DoE) software was used to study the impact of propylene glycol and Poloxamer 188 concentrations on measured responses (liquefying temperature, liquefying time, and GBC solubility). The optimized formulation was subjected to an in vitro dissolution study. The optimized T-SNEDDS consisted of Kolliphor EL and Imwitor 308 as surfactants and oil. The optimized propylene glycol and Poloxamer 188 concentrations were 13.7 and 7.9% w/w, respectively. It exhibited a liquefying temperature of 35.0 °C, a liquefying time of 119 s, and a GBC solubility of 5.51 mg/g. In vitro dissolution study showed that optimized T-SNEDDS exhibited 98.8% dissolution efficiency compared with 2.5% for raw drugs. This study presents a promising approach to enhance pharmaceutical applicability by resolving the limitations of traditional SNEDDS. Full article
Show Figures

Figure 1

Figure 1
<p>Solubility of glibenclamide in different oils.</p>
Full article ">Figure 2
<p>Physical appearance of a dispersed mixture consisting of Imwitor 308 and different types of surfactants.</p>
Full article ">Figure 3
<p>Physical appearance of thermoresponsive SNEDDS formulation: (<b>A</b>) Solid state at room temperature (25 °C), and (<b>B</b>) Liquid state at body temperature (37 °C).</p>
Full article ">Figure 4
<p>Three-dimensional surface plots showing the influence of propylene glycol and Poloxamer 188 concentrations on (<b>A</b>) liquefying temperature, (<b>B</b>) liquefying time, and (<b>C</b>) GBC Solubility of the thermoresponsive SNEDDS formulations.</p>
Full article ">Figure 4 Cont.
<p>Three-dimensional surface plots showing the influence of propylene glycol and Poloxamer 188 concentrations on (<b>A</b>) liquefying temperature, (<b>B</b>) liquefying time, and (<b>C</b>) GBC Solubility of the thermoresponsive SNEDDS formulations.</p>
Full article ">Figure 5
<p>Perturbation plots illustrate the effects of (A) propylene glycol (green line) and (B) Poloxamer 188 (Blue line) on (<b>I</b>) liquefying temperature, (<b>II</b>) liquefying time, and (<b>III</b>) GBC Solubility of the in-situ liquefying SNEDDS formulations. The x-axis represents the deviation from the reference point in coded units, while the y-axis shows the response value. Green lines represent propylene glycol, and blue lines represent Poloxamer 188.</p>
Full article ">Figure 5 Cont.
<p>Perturbation plots illustrate the effects of (A) propylene glycol (green line) and (B) Poloxamer 188 (Blue line) on (<b>I</b>) liquefying temperature, (<b>II</b>) liquefying time, and (<b>III</b>) GBC Solubility of the in-situ liquefying SNEDDS formulations. The x-axis represents the deviation from the reference point in coded units, while the y-axis shows the response value. Green lines represent propylene glycol, and blue lines represent Poloxamer 188.</p>
Full article ">Figure 6
<p>Optimization results for thermoresponsive SNEDDS formulation. Each subplot displays the range of values explored for each factor or response, with the blue dot indicating the optimized value within that range.</p>
Full article ">Figure 7
<p>(<b>A</b>) Hard gelatin capsules containing thermoresponsive SNEDDS formulation stored at room temperature. (<b>B</b>) In vitro dissolution profiles of raw GBC and GBC-loaded T-SNEDDS.</p>
Full article ">
15 pages, 2540 KiB  
Article
Dependence of Thermal Conductivity on Size and Specific Surface Area for Different Based CoFe2O4 Cluster Nanofluids
by Javier P. Vallejo, Amir Elsaidy and Luis Lugo
Appl. Sci. 2024, 14(21), 9954; https://doi.org/10.3390/app14219954 - 31 Oct 2024
Viewed by 863
Abstract
Enhancing the thermal conductivity of fluids by using nanoparticles with outstanding thermophysical properties has acquired significant attention for heat-transfer applications. Nanofluids have the potential to optimize energy systems by improving heat-transfer efficiency. In this study, cobalt ferrite nanoparticles clusters with controlled mean sizes [...] Read more.
Enhancing the thermal conductivity of fluids by using nanoparticles with outstanding thermophysical properties has acquired significant attention for heat-transfer applications. Nanofluids have the potential to optimize energy systems by improving heat-transfer efficiency. In this study, cobalt ferrite nanoparticles clusters with controlled mean sizes ranging from 97 to 192 nm were synthesized using a solvothermal method to develop novel nanofluids with enhanced thermal conductivity. These clusters were comprehensively characterized using transmission electron microscopy, X-ray diffraction, Raman spectroscopy, vibrating-sample magnetometry, and nitrogen physisorption. The CoFe2O4 cluster nanofluids were prepared using the two-step method with various base fluids (water, propylene glycol, and a mixture of both). Dynamic light scattering analyses of the average Z-size of the dispersed nanoadditives over time revealed that the stability of the dispersions is influenced by cluster size and the proportion of glycol in the base fluid. The thermal conductivity of the base fluid and nine different 0.5 wt% CoFe2O4 cluster nanofluids was measured using the transient hot wire method at temperatures of 293.15, 303.15, and 313.15 K, showing different temperature dependencies. The study also explores the relationships between the thermal conductivity, cluster size, and specific surface area of the nanoadditives. A maximum thermal conductivity enhancement of 4.2% was reported for the 0.5 wt% nanofluid based on propylene glycol containing 97 nm CoFe2O4 clusters. The findings suggest that the specific surface area of nanostructures is a more relevant parameter than size for describing improvements in thermal conductivity. Full article
(This article belongs to the Special Issue Multiscale Heat and Mass Transfer and Artificial Intelligence)
Show Figures

Figure 1

Figure 1
<p>TEM images at 12,000× magnification (scale bar, 500 nm) and particle size distribution of clusters A (red), B (black) and C (blue).</p>
Full article ">Figure 2
<p>(<b>a</b>) XRD patterns of clusters A, B and C, (<b>b</b>) Raman spectra obtained with a 633 nm excitation wavelength, and (<b>c</b>) field-dependent magnetization of cluster A, registered at 300 K.</p>
Full article ">Figure 3
<p>Average Z-size versus time from preparation for the 0.10 wt% (<b>a</b>) W-based and (<b>b</b>) PG:W-based static and shaken nanofluids.</p>
Full article ">Figure 4
<p>Thermal conductivities as a function of size of cluster for W (<b>a</b>), PG:W (<b>b</b>) and W-based (<b>c</b>) nanofluids.</p>
Full article ">Figure 5
<p>Thermal conductivity enhancements as a function of size of cluster for (<b>a</b>) W, (<b>b</b>) PG:W and (<b>c</b>) PG-based nanofluids.</p>
Full article ">Figure 5 Cont.
<p>Thermal conductivity enhancements as a function of size of cluster for (<b>a</b>) W, (<b>b</b>) PG:W and (<b>c</b>) PG-based nanofluids.</p>
Full article ">Figure 6
<p>Thermal conductivity-enhancement dependence on the thermal conductivity range of CoFe<sub>2</sub>O<sub>4</sub>-based nanofluids.</p>
Full article ">Figure 7
<p>Specific surface area (SSA) as a function of TEM size for the clusters of Fe<sub>3</sub>O<sub>4</sub>/γ-Fe<sub>2</sub>O<sub>3</sub> [<a href="#B24-applsci-14-09954" class="html-bibr">24</a>] and CoFe<sub>2</sub>O<sub>4</sub> [this work].</p>
Full article ">
22 pages, 4563 KiB  
Article
Physically Cross-Linked PVA Hydrogels as Potential Wound Dressings: How Freezing Conditions and Formulation Composition Define Cryogel Structure and Performance
by Anna Górska, Ewelina Baran, Justyna Knapik-Kowalczuk, Joanna Szafraniec-Szczęsny, Marian Paluch, Piotr Kulinowski and Aleksander Mendyk
Pharmaceutics 2024, 16(11), 1388; https://doi.org/10.3390/pharmaceutics16111388 - 28 Oct 2024
Viewed by 1190
Abstract
Objectives: Hydrogels produced using the freeze–thaw method have demonstrated significant potential for wound management applications. However, their production requires precise control over critical factors including freezing temperature and the choice of matrix-forming excipients, for which no consensus on the optimal conditions currently [...] Read more.
Objectives: Hydrogels produced using the freeze–thaw method have demonstrated significant potential for wound management applications. However, their production requires precise control over critical factors including freezing temperature and the choice of matrix-forming excipients, for which no consensus on the optimal conditions currently exists. This study aimed to address this gap by evaluating the effects of the above-mentioned variables on cryogel performance. Methods: Mechanical properties, absorption capacity, and microstructure were assessed alongside advanced analyses using differential scanning calorimetry (DSC) and low-field nuclear magnetic resonance relaxometry (LF TD NMR). Results: The results demonstrated that fully hydrolyzed polyvinyl alcohol (PVA) with a molecular weight above 61,000 g/mol is essential for producing high-performance cryogels. Among the tested formulations, an 8% (w/w) PVA56–98 solution (Mw~195,000; DH = 98.0–98.8%) with 10% (w/w) propylene glycol (PG) provided the best balance of stretchability, durability, and low adhesion. Notably, while −25 °C is often used for cryogel preparation, freezing the gel precursor at −80 °C yielded superior results, producing materials with more open, interconnected structures and enhanced mechanical strength and elasticity—deviating from conventional practices. Conclusions: The designed cryogel prototypes exhibited functional properties comparable to or even surpassing commercial wound dressings, except for absorption capacity, which remained lower. Despite this, the cryogel prototypes demonstrated potential as wound dressings, particularly for use in dry or minimally exuding wounds. All in all, this study provides a comprehensive analysis of the physicochemical and functional properties of PVA cryogels, establishing a strong foundation for the development of advanced wound dressing systems. Full article
(This article belongs to the Special Issue Prospects of Hydrogels in Wound Healing)
Show Figures

Figure 1

Figure 1
<p>Visual appearance of hydrogel membranes prepared with different PVA concentrations (5%, 8%, 10%) and freezing methods, showing structural differences due to varying preparation conditions.</p>
Full article ">Figure 2
<p>SEM images of hydrogel dressings prepared with varying PVA<sub>56–98</sub> concentrations and freezing temperatures, captured after 48 h of lyophilization at 1500× magnification.</p>
Full article ">Figure 3
<p>Comparative water uptake (Uw) of lab-developed (<b>panel A</b>) and commercial hydrogel wound dressings (<b>panel B</b>). Panel A shows the effect of cryogel composition (8% and 10% PVA<sub>56–98</sub>) and preparation method (−25 °C (A), −80 °C (B), −78 °C (C), and −196 °C (D)) on Uw capacity.</p>
Full article ">Figure 4
<p>Comparative analysis of mechanical properties: lab-developed dressings (M8_PG10, M10_PG10) vs. commercial hydrogel wound dressings (Product_1, Product_2)—the impact of composition and freezing conditions on elasticity and mechanical strength.</p>
Full article ">Figure 5
<p>Thermograms of 8% (<span class="html-italic">w</span>/<span class="html-italic">w</span>) PVA<sub>56–98</sub> cryogels formed at various freezing temperatures: (<b>A</b>) full range and (<b>B</b>) magnified region from −120 °C to 0 °C.</p>
Full article ">Figure 6
<p>Time-dependent weight loss of M8 samples during cooling and heating cycles.</p>
Full article ">Figure 7
<p>Graph of the dependence of parameters obtained from fitting function (3) to the data using the CPMG method, (<b>A</b>) amplitudes, and (<b>B</b>) relaxation times depending on the cycle.</p>
Full article ">Figure 8
<p>T<sub>1</sub>–T<sub>2</sub> maps for selected hydrogel membranes obtained by cyclic freezing and thawing. (<b>A</b>) Freezing temperature of −25 °C; (<b>B</b>) Freezing temperature of −80 °C.</p>
Full article ">
16 pages, 8877 KiB  
Article
Permeability and Toxicity of Cryoprotective Agents in Silkworm Embryos: Impact on Cryopreservation
by David Urbán-Duarte, Shuichiro Tomita, Hiroki Sakai, Hideki Sezutsu, Horacio Álvarez-Gallardo, Yooichi Kainoh, Seiichi Furukawa and Keiro Uchino
Int. J. Mol. Sci. 2024, 25(21), 11396; https://doi.org/10.3390/ijms252111396 - 23 Oct 2024
Viewed by 700
Abstract
The permeation of cryoprotectants into insect embryos is critical for successful cryopreservation. However, the permeability of silkworm embryos to cryoprotectants and the effects of cryopreservation remain poorly studied. In this study, we evaluated the permeability and toxicity of four cryoprotective agents (CPAs) as [...] Read more.
The permeation of cryoprotectants into insect embryos is critical for successful cryopreservation. However, the permeability of silkworm embryos to cryoprotectants and the effects of cryopreservation remain poorly studied. In this study, we evaluated the permeability and toxicity of four cryoprotective agents (CPAs) as well as the vitrification effect on the viability of silkworm embryos. Among the four CPAs, propylene glycol (PG) showed the best permeability. Ethylene glycol (EG) and PG were the least toxic CPAs, but glycerol (GLY) and dimethyl sulfoxide (DMSO) were more toxic. Moreover, we examined several factors including the kind and the concentration of CPAs, exposure time, embryonic stage, and silkworm strains. Embryos at the earlier phases of stage 25 were more tolerant to vitrification using EG. We found that over 21% of embryos treated with EG at the early 2 phase of stage 25: 163 h after egg laying (AEL) developed and progressed to serosa ingestion after vitrification and rewarming. The result was the same in other strains as well. Our results are valuable for the development of new cryopreservation protocols of silkworm embryos. Full article
(This article belongs to the Special Issue Progress of Molecular Biology and Physiology in Lepidopteran Insects)
Show Figures

Figure 1

Figure 1
<p>The relative area of embryos at the early 1 phase-stage 25 (appearance of taenidium, 160 h AEL) during exposure to DMSO, EG, GLY, and PG solutions and different concentrations. The permeabilized embryos of the pnd-w1 strain were exposed to 0.5, 1, 2, and 4 M of CPAs for 120 min at 25 °C. The experiment was repeated three times (<span class="html-italic">n</span> = 3); 9–12 eggs were used in each replicate experiment. Symbol marks and error bars represent the mean ± SE.</p>
Full article ">Figure 2
<p>The relative area of embryos at the early 1 phase-stage 25 (appearance of taenidium, 160 h AEL) during exposure to 2 M DMSO, EG, GLY, and PG solutions. The permeabilized embryos of the pnd-w1 strain were exposed to CPAs for 120 min at 25 °C. The experiment was repeated three times (<span class="html-italic">n</span> = 3); 10–12 eggs were used in each replicate experiment. Symbol marks and error bars represent the mean ± SE.</p>
Full article ">Figure 3
<p>Effect of different 2 M CPAs on embryos at the early 1 phase-stage 25 (appearance of taenidium; 160 h AEL). (<b>A</b>) The permeabilized embryos of the pnd-w1 strain were exposed to 2 M DMSO, EG, GLY, and PG solutions for 30 min at 25 °C. <span class="html-italic">Permeabilized</span> represents no exposure to CPA solution. The experiment was repeated nine times (<span class="html-italic">n</span> = 9); 12 embryos were used in each replicate experiment. Bars and error bars represent the mean ± SE. * <span class="html-italic">p</span> &lt; 0.05 (Kruskal–Wallis test and post hoc Dunn’s test). (<b>B</b>) Images of embryos 2 days (216 h AEL) after exposure to 2 M CPAs for 30 min. Scale bar: 500 µm.</p>
Full article ">Figure 4
<p>Effect of exposure time in 2 M EG and PG solutions on embryos at the early 1 phase-Stage 25 (appearance of taenidium; 160 h AEL). The permeabilized embryos of the pnd-w1 strain were exposed to 2 M EG and PG solutions for 30, 60, 90, and 120 min at 25 °C. Permeabilized represents no exposure to CPAs. The experiment was repeated four to six times (<span class="html-italic">n</span> = 4–6); 10–12 embryos were used in each replicate experiment. Bars and error bars represent the mean ± SE. * <span class="html-italic">p</span> &lt; 0.05 (Kruskal–Wallis test and post hoc Dunn’s test).</p>
Full article ">Figure 5
<p>Images of embryos at the early 1 phase-stage 25 (appearance of taenidium; 160 h AEL) of the pnd-w1 strain after exposure to CPAs. The permeabilized embryos were exposed to 2 M EG and PG solutions. (<b>A</b>) No damaged embryo after 60 min of exposure to EG solution. (<b>B</b>) Damaged embryo after 60 min of exposure to EG solution. (<b>C</b>) No damaged embryo after 90 min of exposure to PG solution. (<b>D</b>) Damaged embryo after 90 min of exposure to PG solution. Scale bar: 500 µm.</p>
Full article ">Figure 6
<p>Effect of exposure time in vitrification solutions on embryos at the early 1 phase-stage 25 (appearance of taenidium; 160 h AEL) without immersion in liquid nitrogen. The permeabilized embryos of the pnd-w1 strain were exposed to 2 M EG for 30 min followed by 7.2 M EG solution with 0.5 M trehalose for 5, 10, and 20 min or 2 M PG for 30 min followed by 5.5 M PG solution with 0.5 M trehalose for 5, 10, and 20 min. Permeabilized represents no exposure to CPAs. The experiment was repeated three to four times (<span class="html-italic">n</span> = 3–4); 10–12 embryos were used in each replicate experiment. Bars and error bars represent the mean ± SE. * <span class="html-italic">p</span> &lt; 0.05 (Kruskal–Wallis test and post hoc Dunn’s test).</p>
Full article ">Figure 7
<p>Effect of immersion in liquid nitrogen (vitrification) after different exposure times to vitrification solutions on embryos at the early 1 phase-stage 25 (appearance of taenidium; 160 h AEL). The permeabilized embryos of the pnd-w1 strain were exposed to 2 M EG for 30 min followed by 7.2 M EG solution with 0.5 M trehalose for 5, 10, and 20 min or 2 M PG for 30 min followed by 5.5 M PG solution with 0.5 M trehalose for 5, 10, and 20 min. Next, the embryos were plunged in liquid nitrogen. The experiment was repeated four times (<span class="html-italic">n</span> = 4); 10–12 embryos were used in each replicate experiment. Bars and error bars represent the mean ± SE. * <span class="html-italic">p</span> &lt; 0.05 (Kruskal–Wallis test and post hoc Dunn’s test).</p>
Full article ">Figure 8
<p>Effect of vitrification on embryos at different phases of Stage 25 (appearance of taenidium). The permeabilized embryos of the pnd-w1 strain were exposed to 2 M EG for 30 min followed by 7.2 M EG solution with 0.5 M trehalose for 20 min and immersed in liquid nitrogen; Stage 24, 157 h AEL; Early 1 phase-stage 25, 160 h AEL; Early 2 phase-stage 25, 163 h AEL; Middle 1 phase-stage 25, 166 h AEL. The experiment was repeated four times (<span class="html-italic">n</span> = 4); 9–12 embryos were used in each replicate experiment. Bars and error bars represent the mean ± SE. * <span class="html-italic">p</span> &lt; 0.05 (Kruskal–Wallis test and post hoc Dunn’s test).</p>
Full article ">Figure 9
<p>Development after vitrification and rewarming using early 2 phase-stage 25 (appearance of taenidium; 163 h AEL) embryos of the pnd-w1 strain. The permeabilized embryos were exposed to 2 M EG for 30 min followed by 20 min immersion in a 7.2 M EG solution with 0.5 M trehalose and then plunged into liquid nitrogen. (<b>A</b>) Embryo immediately after rewarming. (<b>B</b>) Embryo 4 days after rewarming (11 days AEL). (<b>C</b>) Embryo without serosa ingestion 8 days after rewarming (15 days AEL). (<b>D</b>) Embryos with serosa ingestion 8 days after rewarming (15 days AEL). Scale bar: 500 µm.</p>
Full article ">Figure 10
<p>Effect of vitrification on embryos at the early 2 phase-stage 25 (appearance of taenidium; 163 h AEL) of the diapausing strain w1. The permeabilized embryos were exposed to 2 M EG for 30 min followed by 7.2 M EG solution with 0.5 M trehalose for 20 min and immersed in liquid nitrogen. (<b>A</b>) Proportion of embryos developing to head pigmentation and embryos developing to serosa ingestion. The experiment was repeated three times (<span class="html-italic">n</span> = 3); 11–12 embryos were used in each replicate experiment. Bars and error bars represent the mean ± SE. (<b>B</b>) Embryo immediately after warming. (<b>C</b>) Embryo 4 days after warming (11 days AEL). White arrow indicates damaged tissue. Scale bar: 500 µm.</p>
Full article ">Figure 11
<p>Protocol for cryopreservation of silkworm embryos. (<b>A</b>) Outline of vitrification protocol. The permeabilized embryos attached to a nylon net were immersed in 2 M CPA solution at 25 °C, blotted on filter paper to remove the excess solution, transferred to the vitrification solution at 4 °C, blotted on filter paper to remove the excess solution, and finally plunged into liquid nitrogen. The composition of the CPA and vitrification solutions varied in the defined experiments. (<b>B</b>) Outline of rewarming. The vitrificated embryos were exposed to vapor nitrogen for 1 min (around 1 cm above liquid nitrogen), then rewarmed in 0.5 M trehalose solution at 40 °C, followed by 0.25 M and 0.125 M trehalose solutions. Finally, the embryos were immersed twice in Grace’s medium.</p>
Full article ">
18 pages, 4517 KiB  
Article
Energy-Saving Extractive Distillation Process for Isopropanol Dehydration with Propylene Glycol as Novel Extractive Solvent
by Marilena Nicolae, Mihaela Neagu and Diana Luciana Cursaru
Appl. Sci. 2024, 14(20), 9420; https://doi.org/10.3390/app14209420 - 16 Oct 2024
Cited by 2 | Viewed by 928
Abstract
The extractive distillation process using propylene glycol (IUPAC name: 1,2 propanediol) as an extractive agent for the separation of the isopropanol–water system was investigated in this work. A systematic procedure was set out to obtain the optimal design and process conditions for extractive [...] Read more.
The extractive distillation process using propylene glycol (IUPAC name: 1,2 propanediol) as an extractive agent for the separation of the isopropanol–water system was investigated in this work. A systematic procedure was set out to obtain the optimal design and process conditions for extractive distillation and solvent recovery columns using the PRO/II process simulator. Four thermally integrated flowsheets were proposed, implying the recovery of the sensible heat and latent heat from the hot streams in the process. To establish the economic feasibility of the proposed process, we calculated the total annual cost for all the simulated versions, and the proposed fully thermally integrated flowsheets could save up to 43.13% in terms of the utility costs and up to 15.57% in terms of the TAC compared to the conventional design. Thus, propylene glycol (PG) is found to be suitable as a new solvent for isopropanol dehydration, being comparable with other classical solvents used for the dehydration of alcohols. Full article
(This article belongs to the Section Applied Industrial Technologies)
Show Figures

Figure 1

Figure 1
<p>Steady-state PRO/II flowsheet for the IPA–water separation process.</p>
Full article ">Figure 2
<p>Two process flowsheet diagrams proposed for the recovery of the sensible heat from the hot streams: (<b>a</b>) SH1; and (<b>b</b>) SH2.</p>
Full article ">Figure 3
<p>Two process flowsheet diagrams proposed for the recovery of the latent heat and sensible heat from the hot streams: (<b>a</b>) LH-SH1; and (<b>b</b>) LH-SH2.</p>
Full article ">Figure 3 Cont.
<p>Two process flowsheet diagrams proposed for the recovery of the latent heat and sensible heat from the hot streams: (<b>a</b>) LH-SH1; and (<b>b</b>) LH-SH2.</p>
Full article ">Figure 4
<p>The conventional TCED process for IPA–water binary separation with PG as a new extractive solvent proposed in this work.</p>
Full article ">Figure 5
<p>The influence of E/D1 on the water concentrations in the IPA distillation product and EDC reboiler duty (NT2 = 20, NF2 = 16, NFE = 5, RR2 = 0.9).</p>
Full article ">Figure 6
<p>The influence of the NT2 effect on the water concentrations in the IPA product and EDC reboiler’s duty (E/D1 = 3.4/1, NF2 = 16, NFE = 5, RR2 = 0.9).</p>
Full article ">Figure 7
<p>The influence of NF2 on the water concentrations in the IPA product and EDC reboiler’s duty (E/D1 = 3.4/1, NT2 = 30, NFE = 5, RR2 = 0.9).</p>
Full article ">Figure 8
<p>The influence of RR2 on the water concentrations in the IPA product and EDC reboiler’s duty (E/D1 = 3.4/1, NT2 = 30, NFE = 5, NF2 = 20).</p>
Full article ">Figure 9
<p>The TCED process with two configurations for energy saving by recovering the sensible heat from the hot streams: (<b>a</b>) SH1; and (<b>b</b>) SH2.</p>
Full article ">Figure 10
<p>The TCED process with two energy-saving configurations, using both the latent heat of the overhead vapor and the sensible heat of the hot solvent: (<b>a</b>) LH-SH1; and (<b>b</b>) LH-SH2.</p>
Full article ">
11 pages, 3689 KiB  
Article
Isoorientin Improves Excisional Skin Wound Healing in Mice
by Aline B. Hora, Laiza S. Biano, Ana Carla S. Nascimento, Zaine T. Camargo, Greice I. Heiden, Ricardo L. C. Albulquerque-Júnior, Renata Grespan, Jessica M. D. A. Aragão and Enilton A. Camargo
Pharmaceuticals 2024, 17(10), 1368; https://doi.org/10.3390/ph17101368 - 14 Oct 2024
Viewed by 948
Abstract
Background/Objectives: Wound healing relies on a coordinated process with the participation of different mediators. Natural products are a source of active compounds with healing potential. Isoorientin is a natural flavone recognized as having several pharmacological properties, such as anti-inflammatory effects, making it [...] Read more.
Background/Objectives: Wound healing relies on a coordinated process with the participation of different mediators. Natural products are a source of active compounds with healing potential. Isoorientin is a natural flavone recognized as having several pharmacological properties, such as anti-inflammatory effects, making it a potential treatment for wounds. We investigated the effect of isoorientin on the healing of excisional skin wounds. Methods: Male Swiss mice were subjected to the induction of excisional skin wounds (6 mm diameter) and treated with a vehicle (2% dimethyl sulfoxide in propylene glycol) or 2.5% isoorientin applied topically once a day for 14 days. The wound area was measured on days 0, 3, 7, and 14. Histopathological analyses were performed on the cicatricial tissue after 14 days. The myeloperoxidase activity and the interleukin-1β, tumoral necrosis factor (TNF)-α, and interleukin-6 concentrations were determined on the third day. Results: We observed that 3 days after the topical application of isoorientin, the lesion area was significantly smaller when compared to those of the vehicle (p < 0.01) and control (p < 0.05) groups. No difference was observed after 7 and 14 days of induction. Despite this, on day 14, histological analysis of cicatricial tissue from the animals treated with isoorientin showed reduced epidermal thickness (p < 0.001) and increased collagen deposition (p < 0.001). These effects were accompanied by decreased myeloperoxidase activity and interleukin-1β concentration on the third day of induction, without alteration in TNF-α and interleukin-6. Conclusions: The treatment with isoorientin promoted better tissue repair in excisional wounds in mice, which may be linked to the modulation of the early inflammatory response. Full article
(This article belongs to the Special Issue Pharmacological Activities of Flavonoids and Their Analogues 2024)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>The effect of isoorientin on the skin wound area at different time points. Mice were divided into control (no treatment), vehicle (2% dimethyl sulfoxide (DMSO) in propylene glycol), and 2.5% isoorientin (2.5% Iso) groups. The area of each skin lesion was measured at days 0, 3, 7, and 14 after induction, according to the experimental design (<b>A</b>). Representative images of the skin lesions of the groups at different time points are shown (<b>B</b>). The area of the skin lesions (<b>C</b>) is expressed as mean ± SD (n = 10/group at D0, 3, and 7, and n = 6/group at D14). Two-way analysis of variance (ANOVA) and the Bonferroni post hoc test were used. * <span class="html-italic">p</span> &lt; 0.05 or ** <span class="html-italic">p</span> &lt; 0.01 compared to the control or vehicle group, as indicated. Created in BioRender.com.</p>
Full article ">Figure 2
<p>Representative images of the wound tissues 14 days after induction, and quantification of the epidermal thickness. Histological sections stained with hematoxylin and eosin represent each experimental group’s epidermis and papillary/reticular dermis. Panoramic views of the groups—control (<b>A</b>), vehicle (<b>D</b>), 2.5% Iso (<b>G</b>), and healthy skin (<b>J</b>)—show the measurement of the granulation reaction depth (dotted lines with double arrows), epidermal acanthosis (ac), and residual granulation reaction (rgr) in the lamina propria (100×). Details of the granulation reaction and the deeper dermal portion in the control (<b>B</b>,<b>C</b>), vehicle (<b>E</b>,<b>F</b>), 2.5% Iso (<b>H</b>,<b>I</b>), and healthy skin (<b>K</b>,<b>L</b>) groups (400×) are shown. A violin plot shows the measurement of the mean epidermal thickness in the experimental groups (<b>M</b>), n = 6 animals with 6–8 measurements each. The Kruskal–Wallis and Dunn’s post hoc tests were used. *** <span class="html-italic">p</span> &lt; 0.001 and <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 compared to the control or vehicle groups.</p>
Full article ">Figure 3
<p>Representative images of Masson’s trichrome staining, and quantification of collagen deposition in the wound tissues 14 days after induction. Histological sections stained with Masson’s trichrome represent each experimental group’s papillary/reticular dermis area. Panoramic views of the control (<b>A</b>), vehicle (<b>B</b>), 2.5% Iso (<b>C</b>), and healthy tissue (<b>D</b>) groups (100×) are shown, along with the histological appearances of collagen fibers in the experimental groups and normal skin (<b>E</b>–<b>H</b>) (400×). The violin plot demonstrates the dermal collagen optical density (DCOD) determination in the experimental groups (<b>I</b>), n = 6 animals with 7–10 measurements each. Data are expressed as the median and minimum to maximum. Kruskal–Wallis and Dunn’s post hoc tests were used. *** <span class="html-italic">p</span> &lt; 0.001 and <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 compared to the control or vehicle groups.</p>
Full article ">Figure 4
<p>The effect of isoorientin on the myeloperoxidase activity and pro-inflammatory cytokine production in the wound tissues 3 days after induction. Mice were treated daily according to their respective groups: control (no treatment), vehicle (2% DMSO in propylene glycol), or Iso (2.5% Isoorientin). The wounds were analyzed on the third day to measure MPO activity (<b>A</b>) and the concentrations of IL-1β (<b>B</b>), TNF-α (<b>C</b>), and IL-6 (<b>D</b>). Data are expressed as mean ± SD (n = 5). Two-way ANOVA and the Bonferroni post hoc test were used. * <span class="html-italic">p</span> &lt; 0.05 and *** <span class="html-italic">p</span> &lt; 0.0001, respectively, compared to the vehicle group.</p>
Full article ">
22 pages, 5099 KiB  
Article
Capparis sepiaria-Loaded Sodium Alginate Single- and Double-Layer Membrane Composites for Wound Healing
by Sindi P. Ndlovu, Keolebogile S. C. M. Motaung, Mapula Razwinani, Sibusiso Alven, Samson A. Adeyemi, Philemon N. Ubanako, Lindokuhle M. Ngema, Thierry Y. Fonkui, Derek T. Ndinteh, Pradeep Kumar, Yahya E. Choonara and Blessing A. Aderibigbe
Pharmaceutics 2024, 16(10), 1313; https://doi.org/10.3390/pharmaceutics16101313 - 10 Oct 2024
Viewed by 1155
Abstract
Background: Effective wound dressing is the key solution to combating the increased death rate and prolonged hospital stay common to patients with wounds. Methods: Sodium alginate-based single- and double-layer membranes incorporated with Capparis sepiaria root extract were designed using the solvent-casting [...] Read more.
Background: Effective wound dressing is the key solution to combating the increased death rate and prolonged hospital stay common to patients with wounds. Methods: Sodium alginate-based single- and double-layer membranes incorporated with Capparis sepiaria root extract were designed using the solvent-casting method from a combination of polyvinyl alcohol (PVA), Pluronic F127 (PF127), and gum acacia. Results: The successful preparation of the membranes and loading of the extract were confirmed using Fourier transform infrared spectroscopy (FTIR) and X-ray diffraction (XRD). The prepared membranes were biodegradable and non-toxic to human skin cells (HaCaT), with high biocompatibility of 92 to 112% cell viability and good hemocompatibility with absorbance ranging from 0.17 to 0.30. The membrane’s highest water vapor transmission rate was 1654.7333 ± 0.736 g/m2/day and the highest % porosity was 76%. The membranes supported cellular adhesion and migration, with the highest closure being 68% after 4 days compared with the commercial wound dressings. This membrane exhibited enhanced antimicrobial activity against the pathogens responsible for wound infections. Conclusions: The distinct features of the membranes make them promising wound dressings for treating infected wounds. Full article
Show Figures

Figure 1

Figure 1
<p>The FTIR spectra for the prepared SLMs and DLMs.</p>
Full article ">Figure 2
<p>The SEM images for the prepared membranes and <span class="html-italic">Capparis sepiaria</span> extract.</p>
Full article ">Figure 3
<p>XRD for the prepared SLMs and DLMs.</p>
Full article ">Figure 4
<p>Cell viability of HaCaT cells treated with the selected membranes (DLM0, DLM2, DLM4, DLM6, DLM9, SLM3, SLM5, and SLM11), control (commercial wound dressing), and plant extract after 48 h; testing was conducted using an MTT assay at a wavelength of 570 nm.</p>
Full article ">Figure 5
<p>The absorbances of the membranes (DLM0, DLM2. DLM4, DLM6, DLM9, SLM3, SLM5, and SLM11), commercial wound dressing (COM), and <span class="html-italic">Capparis sepiaria</span> plant extract (EXT) were compared to whole blood (WB) at 540 nm, i.e., <span class="html-italic">p</span> &lt; 0.0001–0.0018, with a 95% confidence interval.</p>
Full article ">Figure 6
<p>The images of membranes (DLM2, DLM4, and SLM3), the control, and untreated cells for the wound healing scratch assay.</p>
Full article ">
Back to TopTop